NCT02143271View on ClinicalTrials.gov

Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Secondary Hyperparathyroidism
Interventions
DRUG

KHK7580

Oral administration

Trial Locations (1)

Unknown

Kyowa Hakko Kirin, Tokyo

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT02143271 - Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis | Biotech Hunter | Biotech Hunter